Home » Geron Drug Fails Breast Cancer Trial, Shares Sink
Geron Drug Fails Breast Cancer Trial, Shares Sink
Cancer drugmaker Geron said it would halt the study of its experimental drug, imetelstat, as a treatment for breast cancer and the drug was also unlikely to move forward in trials for advanced non-small cell lung cancer, causing the company’s shares to shed nearly half their value.
Medcity News
Medcity News
Upcoming Events
-
07May
-
14May
-
30May